NCT00512187View on ClinicalTrials.gov

Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2005

Study Completion Date

August 31, 2007

Conditions
Chronic Plaque PsoriasisObesity
Interventions
OTHER

low calorie diet

Low calorie diet was designed to achieve a loss of 5-10% of initial weight. All enrolled patients received a balanced diet scheme, based on a caloric intake reduction related to BMI and sex (range 1200-1500 Kcal/day for women, 1300-1600 Kcal/day for men). Calorie intake consisted approximately of 60% carbohydrates, 25% fat, 15% protein

Trial Locations (1)

37126

University of Verona, Verona

All Listed Sponsors
lead

Universita di Verona

OTHER

NCT00512187 - Moderate Weight Loss Makes Obese Patients With Severe Chronic Plaque Psoriasis Responsive to Sub-Optimal Dose of Cyclosporine: an Investigator Blinded, Controlled, Randomized Clinical Trial | Biotech Hunter | Biotech Hunter